what would be needed to start a real primary prevention trial in Alzheimer’s Disease
Catherine J. Mummery · 2025
Read what would be needed to start a real primary prevention trial in Alzheimer’s Disease by Catherine J. Mummery (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11713513.txt.
Description
Catherine Mummery asks what a true primary prevention trial for Alzheimer's disease would need, in this 2025 paper. Prevention in her sense means treating people before any sign of disease appears. Current trials treat people who already show amyloid or tau, which delays illness rather than preventing it.
Mummery notes that anti-amyloid drugs are prime candidates for such a trial. The hard part is finding healthy people at high risk before pathology starts. That calls for a clear risk sorting plan and markers that predict disease early. She also weighs which drug action to target and the moral questions of treating people who may never fall ill.
Catalog record
| CREATOR | Catherine J. Mummery |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 2 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |